Accuray

Accuray develops, manufactures, and sells radiation therapy systems designed to make cancer treatment shorter, safer, and more effective. Founded in 1990 by Dr. John R. Adler, Jr., a Stanford neurosurgeon, the company began commercial operations in 1992 and is headquartered in Madison, Wisconsin. Its systems are installed in approximately 50 countries.

The company's technical work spans robotic radiosurgery, stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), image-guided intensity-modulated radiation therapy, and AI-driven real-time motion synchronization. Two product lines anchor the portfolio. The CyberKnife System is a robotic radiosurgery device that delivers SRS and SBRT with robotic precision and AI-driven, real-time motion synchronization. The Radixact System is the latest generation of the TomoTherapy platform, integrating 3D kVCT and megavoltage CT imaging for advanced image-guided intensity-modulated radiation therapy.

Accuray works within the oncology, radiation therapy, and medical devices sectors. Its stated mission is to expand the curative power of radiation therapy to improve as many lives as possible. Corporate social responsibility activity is organised around five pillars aligned with the UN 2030 Sustainable Development Goals: expanding access to healthcare, building strong communities, fostering inclusion and diversity, enhancing environmental sustainability, and maintaining trust and accountability.